image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 29.11
-3.64 %
$ 3.6 B
Market Cap
-6.8
P/E
CASH FLOW STATEMENT
-325 M OPERATING CASH FLOW
-5.01%
840 M INVESTING CASH FLOW
460.85%
477 M FINANCING CASH FLOW
352.46%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Guardant Health, Inc.
image
Net Income -479 M
Depreciation & Amortization 42.9 M
Capital Expenditures -20.5 M
Stock-Based Compensation 90.8 M
Change in Working Capital 53.8 M
Others -65.8 M
Free Cash Flow -345 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (479.4) (654.6) (384.8) (246.3) (67.9) (84.3) (83.2) (46.1)
Depreciation & Amortization 42.9 36.0 22.3 16.1 13.6 7.1 5.2 3.7
Deferred Income Tax 0 0 12.9 11.2 (1.6) (0.8) 6.4 0.3
Stock Based Compensation 90.8 94.7 151.4 144.1 17.0 6.9 3.7 2.0
Other Operating Activities (33.0) 152.9 29.6 18.7 (2.2) 13 K 0.7 1.0
Change in Working Capital 53.8 61.6 (40.5) (47.7) (6.1) (1.1) (5.0) 2.5
Cash From Operations (325.0) (309.5) (209.0) (103.9) (47.1) (72.2) (72.2) (36.7)
INVESTING CASH FLOW
Capital Expenditures (20.5) (77.5) (75.0) (54.1) (21.3) (20.2) (9.0) (1.8)
Other Items 860.7 227.3 11.9 (563.0) (296.3) (132.8) (161.4) 28.0
Cash From Investing Activities 840.2 149.8 (63.2) (617.1) (317.6) (153.0) (170.4) 26.2
FINANCING CASH FLOW
Common Stock Repurchased 0 (7.9) (83.8) (3.4) 0 (0.2) (12.6) 100 K
Total Debt Repaid 0 71 K (0.1) 1 132.6 (0.1) (0.4) (26.1) (0.4)
Dividends Paid 0 0 0 0 0 (3.2) 0 0
Other Financing Activities (15.7) (189.0) (66.7) (78.0) 17.0 39.8 315.0 40.3
Cash From Financing Activities 477.4 (189.1) (66.8) 1 410.3 367.3 293.2 281.7 39.8
CHANGE IN CASH
Net Change In Cash 991.7 (842.6) (340.7) 689.7 2.7 67.9 39.0 29.3
FREE CASH FLOW
Free Cash Flow (345.5) (386.9) (284.1) (158.0) (68.4) (92.4) (81.2) (38.5)